Tabula Rasa Healthcare

Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services. Its brands include CareKinesis, Capstone Risk Adjustment Services, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides Medication Therapy Management, or MTM, software and services for Medicare, Medicaid, and commercial health plans, and also provides a cloud-based patient engagement software and services. It offers cloud-based software and clinical pharmacist services through its brands, including MedWise, SinfoníaRx, RxCompanion, PrescribeWellness, and DoseMeRx. The company was founded by Calvin H. Knowlton, Orsula V. Knowlton, and Michael Greenhalgh in April 2009 and is headquartered in Moorestown, NJ.

Earnings data Q4 2019

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q2 2024

Tabula Rasa HealthCare reports robust Q4 growth and strategic investments

Tabula Rasa HealthCare's Q4 2022 performance reflects strong revenue growth and strategic initiatives to enhance profitability.
While facing challenges in technology-enabled solutions revenue and execution risks, the company is well-positioned for growth.
Opportunities in automation investments and MedWise platform expansion offer avenues for sustained revenue growth and market impact.

Tabula Rasa HealthCare (TRHC) excels in Q1 2023 earnings, eyes expansion

Tabula Rasa HealthCare (TRHC) delivered strong financial performance in Q1 2023, driven by revenue growth, profitability focus, and strategic initiatives.
The company faces challenges from drug price inflation and contract turnover impact but is well-positioned for future expansion and market penetration.
TRHC's emphasis on customer-centric strategies, PACE program growth, and efficient resource management sets the stage for continued success and revenue growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tabula Rasa provides state-of-the-art medication management through a combination of technology, science and services that reduces costs, improves the quality of care and decreases the risks associated with ineffective medication plans.

ORLANDO, Fla.--(BUSINESS WIRE)--Transaction Data Systems (TDS), the leader in pharmacy software solutions, today announced the successful completion of its acquisition of PrescribeWellness from Tabula Rasa HealthCare, Inc.® (TRHC). PrescribeWellness is a market-leading patient relationship management company with a proven track record of facilitating patient, payor, provider, and pharmaceutical company engagement for more than 15,000 pharmacies in the U.S., Canada, and Puerto Rico. “Independent

Transaction Data Systems Completes Acquisition of PrescribeWellness

MOORESTOWN, N.J. , Aug. 1, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® ("TRHC" or the "Company") (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, announced today that it completed the previously announced sale of its PrescribeWellness business to Transaction Data Systems, Inc. ("TDS") for an all-cash purchase price of up to $140 million.

Tabula Rasa HealthCare Completes Sale of PrescribeWellness to Transaction Data Systems for $140 Million

Tabula Rasa Healthcare (TRHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tabula Rasa Healthcare (TRHC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

SAN FRANCISCO--(BUSINESS WIRE)--Indaba Capital Management L.P. (together with its affiliates, “Indaba” or “we”), which is the largest shareholder of Tabula Rasa HealthCare Inc. (NASDAQ: TRHC) (“Tabula Rasa” or the “Company”) and beneficially owns approximately 25.2% of the Company's outstanding shares, today announced that pursuant to Section 220 of the Delaware General Corporation Law, it has requested that Tabula Rasa make available for inspection and copying the books and records (the “Books

Indaba Capital Delivers Demand for Inspection of Books and Records of Tabula Rasa HealthCare, Pursuant to Section 220 of Delaware Law

MOORESTOWN, N.J. , July 27, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced a five-year contract renewal with Trinity Health PACE for TRHC's CareKinesis® PACE Pharmacy services.

Tabula Rasa HealthCare Announces Five-Year Contract Extension with Trinity Health PACE

Responds to Substantial Stock Accumulation by Indaba Capital Management Protects Long-Term Value of All Stockholders' Investments in Tabula Rasa MOORESTOWN, N.J. , July 26, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("Tabula Rasa," "TRHC" or the "Company") (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration stockholder rights plan ("Rights Plan") under which stockholders will receive rights to purchase a new series of preferred stock in certain circumstances.

Tabula Rasa HealthCare Adopts Limited-Duration Stockholder Rights Plan

MOORESTOWN, N.J. , July 25, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ: TRHC), will hold a conference call and webcast to discuss its second quarter 2022 operating results Friday, August 5, 2022 at 8:30 a.m.

Tabula Rasa HealthCare Schedules Second Quarter 2022 Earnings Conference Call

Tabula Rasa HealthCare Inc (NASDAQ: TRHC) expects Q2 sales of $72 – $73 million, exceeding the prior guidance range of $66 – $69 million and the consensus of $67.61 million. Gordon Tunstall, TRHC's Lead Independent Director, said that the Board and management team have.

Tabula Rasa Sees Better Than Expected Q2 Sales, Just As Investor Calls For Removal Of Top Executives

Reports Preliminary Revenue from Continuing Operations of $72 to $73 Million for the Second Quarter of 2022, Exceeding Prior Guidance Range and Continuing Strong 2022 Performance as Company Focuses on Core Business Company Comments on Public Statements by Indaba Capital Management MOORESTOWN, N.J. , July 20, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("TRHC" or the "Company") (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today reported preliminary unaudited financial results for the second quarter ended June 30, 2022 and commented on public statements made today by Indaba Capital Management, L.P.

Tabula Rasa HealthCare Announces Preliminary Second Quarter 2022 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Indaba Capital Management L.P. (together with its affiliates, “Indaba” or “we”), which is the largest shareholder of Tabula Rasa HealthCare Inc. (NASDAQ: TRHC) (“Tabula Rasa” or the “Company”) with an ownership interest of approximately 19.99% of the Company's outstanding shares, today issued an open letter to the independent members of the Company's Board of Directors (the “Board”): Samira K. Beckwith, Jan Berger, MD, MJ, Dennis K. Helling, PharmD, ScD, Kathy O'

Indaba Capital Issues Letter to Tabula Rasa's Independent Directors Regarding the Urgent Need for Management Changes and a Board Refresh

The Companies also Agree to a Strategic Multi-Year Partnership MOORESTOWN, N.J. , June 21, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, announced today that it has entered into a definitive agreement to sell its PrescribeWellness business, a provider of best-in-class patient relationship management solutions, to Transaction Data Systems (TDS).

Tabula Rasa HealthCare Agrees to Sell its PrescribeWellness Business to Transaction Data Systems

Nearly 40 PACE executives expected to attend this year's conference more than doubling 2021 Summit attendance MOORESTOWN, N.J. , June 7, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ®  (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, will host its 2022 CareVention HealthCare Advisory Summit for Program of All-Inclusive Care for the Elderly (PACE) Executives in Phoenix, AZ on June 22 & 23, 2022, providing a forum for discussion on the opportunities to further accelerate the future of PACE.

4th Annual CareVention HealthCare Summit Attracts Record Interest

RBC Capital Markets believe that the market has been assigning little-to-no value to Tabula Rasa HealthCare Inc's (NASDAQ: TRHC) MedWise, which has been burning cash and clouding, a strong core PACE business.  The analyst lowered the price target to $6 from $8, with an.

Why This Analyst Thinks Tabula Rasa's Divestiture Plans 'An Important Step'

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC ) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Kevin Dill – Corporate Counsel Calvin Knowlton – Founder, Chairman and Chief Executive Officer Orsula Knowlton – Founder, President and Chief Marketing Officer Brian Adams – President Tom Cancro – Chief Financial Officer Conference Call Participants Sean Dodge – RBC Capital Markets Glen Santangelo – Jefferies Stephanie Davis – SVB Securities Jessica Tassan – Piper Sandler David Grossman – Stifel Operator Thank you for standing by. And welcome to the Tabula Rasa HealthCare First Quarter 2022 Earnings Conference Call.

Tabula Rasa HealthCare's (TRHC) CEO Calvin Knowlton on Q1 2022 Results -Earnings Call Transcript

First quarter 2022 revenue of $67.1 million from continuing operations includes CareVention HealthCare revenue of $66.3 million, up 19% vs. a year ago Planned sales of PrescribeWellness, SinfoníaRx, and DoseMe expected to add significant liquidity, reduce net debt, and provide financial flexibility GAAP net loss from continuing operations of $20.4 million Adjusted EBITDA of $2.5 million MOORESTOWN, N.J.

Tabula Rasa HealthCare Reports First Quarter 2022 Results

MOORESTOWN, N.J. , April 21, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its first quarter 2022 operating results Friday, May 6, 2022 at 8:30 a.m.

Tabula Rasa HealthCare Schedules First Quarter 2022 Earnings Conference Call

TRHC will continue to provide the North County San Diego PACE program with medication safety, pharmacy, and pharmacy benefit solutions MOORESTOWN, N.J. , March 29, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced a five-year renewal with Gary and Mary West PACE for its CareKinesis PACE Pharmacy and Pharmastar services.

Tabula Rasa HealthCare Announces Partnership Extension with Gary and Mary West PACE

PACE participants who received their medication through CareKinesis® had significantly reduced annual medical expenses related to unintended multi-drug interactions compared to other pharmacies MOORESTOWN, N.J. , March 17, 2022 /PRNewswire/ -- Technology that uses simultaneous, accumulative, multi-drug interactions to identify potential medication risk has been proven to improve patients' health and well-being.

New Study Further Validates Cost Savings from Unique Medication Risk Mitigation Technology

Tabula Rasa HealthCare, Inc. (TRHC) CEO Calvin Knowlton on Q4 2021 Results - Earnings Call Transcript

MOORESTOWN, N.J., Feb. 24, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("TRHC") (Nasdaq: TRHC), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the fourth quarter and full year ended December 31, 2021.

Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2021 Results

MOORESTOWN, N.J., Feb. 14, 2022 /PRNewswire/ --  Tabula Rasa HealthCare, Inc. ®  (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, has signed an agreement with HopeWest to implement the full line of TRHC's CareVention HealthCare™ PACE (Program of All-Inclusive Care for the Elderly) services, including risk adjustment, personalized medication safety and pharmacy services, PACE consulting, electronic health record technology implementation, and third party administration.

HopeWest to Employ Full Line of TRHC's CareVention HealthCare Offerings to Support PACE Startup

MOORESTOWN, N.J., Feb. 10, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its fourth quarter and full year 2021 operating results  Friday, February 25, 2022 at 8:30 a.m.

Tabula Rasa HealthCare Schedules Fourth Quarter 2021 Earnings Conference Call

MOORESTOWN, N.J., Feb. 9, 2022 /PRNewswire/ --  Tabula Rasa HealthCare, Inc.® (TRHC)  (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, announced today that it has signed a non-binding Letter of Intent to sell its DoseMeRx solution.

Tabula Rasa Healthcare to Sell DoseMeRx

MOORESTOWN, N.J., Jan. 4, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.®  (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced a five-year contract renewal with Evernorth℠, a premier health services business that connects and coordinates innovative and flexible solutions for health plans, employers, and government programs, to expand use of TRHC's Medication Therapy Management (MTM) programs and other clinical services.

Tabula Rasa HealthCare and Evernorth Extend Agreement Expanding Medication Safety, Efficacy, and Adherence Services

MOORESTOWN, N.J., Dec. 9, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced the results of two peer-reviewed studies that explore the potential for drug interactions among those who use opioids and take multiple medications.

News for Tabula Rasa Healthcare Stock (TRHC)